Omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine
Omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine has been studied in 1 paper since 2011: 1 trial in people. The newest paper, Apr 29, 2011: “A combination of (ω-3) polyunsaturated fatty acids, polyphenols and L-carnitine reduces the plasma lipid levels and increases the expression of genes involved in fatty acid oxidation in human peripheral blood mononuclear cells and HepG2…”.
1 paper studies it2 findingsUpdated
See all 1 papers on omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine
At a glance
The findings reach people, from one lab or study. 1 lab in 3 countries.
“PPC consumption led to significantly reduced plasma free fatty acid (-29%) and triglyceride (-24%) concentrations (each p < 0.05).”
None of its findings points the other way.
- 1 lab in 3 countries
- Funder: Hochschuljubiläumsstiftung der Stadt Wien
- Human trial1
Studies in people
1 study gave omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases free fatty acids-29% | Randomized trial12 weeks | In moderately hyperlipidemic obese humans | Annals of nutrition & metabolism, Apr 29, 2011 |
What did studies of omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine find?
2Studies of omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine measured 2 outcomes: PPARA and free fatty acids.
PPARA
upin humans1
1 study
PPARA
upin humans1
Omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine increases PPARA in moderately hyperlipidemic obese humans (p < 0.05).
“PPC application increased significantly peroxisome proliferator-activated receptor α (PPARα) mRNA abundances and those of PPARα target genes”
Human trialin moderately hyperlipidemic obese humanslow-fat yoghurt enriched with PPCPBMCs12 weeks
Annals of nutrition & metabolism
Free fatty acids
downin humans1−29%
1 study
Free fatty acids
downin humans1−29%
Omega-3 polyunsaturated fatty acids + polyphenols + levocarnitine decreases free fatty acids in moderately hyperlipidemic obese humans (-29%).
“PPC consumption led to significantly reduced plasma free fatty acid (-29%) and triglyceride (-24%) concentrations (each p < 0.05).”
Human trialin moderately hyperlipidemic obese humanslow-fat yoghurt enriched with PPC12 weeks
Annals of nutrition & metabolism